BAP1 disrupts the BRCA1:BARD1 heterodimer

Stable Identifier
Reaction [dissociation]
Homo sapiens
Locations in the PathwayBrowser
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout

Binding of BAP1 to the BRCA1:BARD1 heterodimer disrupts the BRCA1:BARD1 association and consequently inhibits its E3 ubiquitin ligase activity. Downregulation of BAP1 expression results in the hypersensitivity of cells to ionizing radiation and in retardation of S phase progression, suggesting that BAP1 coordinates the enzymatic activity of the BRCA1:BARD1 complex during DNA double strand break response and during cell cycle (Nishikawa et al. 2009). While BAP1 is a deubiquitinating enzyme and may deubiquitinate some BRCA1:BARD1 substrates, it does not deubiquitinate autoubiquitinated BRCA1 and BARD1 (Mallery et al. 2002, Nishikawa et al. 2009). A catalytically-inactive mutant of BAP1, BAP1 C91S, is still able to inhibit BRCA1:BARD1-mediated ubiquitination, implying that BAP1 primarily regulates the action of the BRCA1:BARD1 complex by disrupting it (Nishikawa et al. 2009).

Literature References
PubMed ID Title Journal Year
19117993 BRCA1-associated protein 1 interferes with BRCA1/BARD1 RING heterodimer activity

Kojima, R, Fukuda, M, Koike, A, Nishikawa, H, Ohta, T, Wu, W, Gomi, H

Cancer Res. 2009
Orthologous Events
Cite Us!